NDC Code | 43742-1379-1 |
Package Description | 30 mL in 1 BOTTLE, DROPPER (43742-1379-1) |
Product NDC | 43742-1379 |
Product Type Name | HUMAN OTC DRUG |
Proprietary Name | Male Stimulant |
Non-Proprietary Name | Aralia Quinquefolia, Agnus Castus, Ascorbicum Acidum, Caladium Seguinum, Kali Bromatum, Cantharis, Damiana, Funiculus Umbilicalis Suis, Glandula Suprarenalis Suis, Hypophysis Suis, Orchitinum (suis), Prostate (suis), Strychninum Phosphoricum, Conium Maculatum, Diencephalon (suis), Heart (suis), Ferrum Phosphoricum, Magnesia Phosphorica, Selenium Metallicum, Zincum Metallicum, Pineal Gland (suis), Cortisone Aceticum, Manganum Phosphoricum, Lycopodium Clavatum, Testosterone, Morgan Gaertner |
Dosage Form | LIQUID |
Usage | ORAL |
Start Marketing Date | 20180905 |
Marketing Category Name | UNAPPROVED HOMEOPATHIC |
Manufacturer | Deseret Biologicals, Inc. |
Substance Name | AMERICAN GINSENG; ASCORBIC ACID; CHASTE TREE FRUIT; CONIUM MACULATUM FLOWERING TOP; CORTISONE ACETATE; DIEFFENBACHIA SEGUINE WHOLE; FERROSOFERRIC PHOSPHATE; LYCOPODIUM CLAVATUM SPORE; LYTTA VESICATORIA; MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE; MANGANESE PHOSPHATE, DIBASIC; PORK HEART; POTASSIUM BROMIDE; SALMONELLA ENTERICA SUBSP. ENTERICA SEROVAR ENTERITIDIS; SELENIUM; STRYCHNINE PHOSPHATE DIHYDRATE; SUS SCROFA ADRENAL GLAND; SUS SCROFA DIENCEPHALON; SUS SCROFA PINEAL GLAND; SUS SCROFA PITUITARY GLAND; SUS SCROFA PROSTATE; SUS SCROFA TESTICLE; SUS SCROFA UMBILICAL CORD; TESTOSTERONE; TURNERA DIFFUSA LEAFY TWIG; ZINC |
Strength | 4; 6; 6; 8; 13; 6; 10; 28; 8; 10; 20; 8; 6; 30; 10; 8; 8; 8; 12; 8; 8; 8; 8; 30; 8; 10 |
Strength Unit | [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL |
Pharmacy Classes | Androgen Receptor Agonists [MoA], Androgen [EPC], Androstanes [CS], Ascorbic Acid [CS], Calculi Dissolution Agent [EPC], Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Magnetic Resonance Contrast Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Paramagnetic Contrast Agent [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE], Vitamin C [EPC] |
DEA Schedule | CIII |